KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Total Debt Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.48%
Dec 31, 2025 -6.51%
Sep 30, 2025 -4.63%
Jun 30, 2025 -4.58%
Mar 31, 2025 1.53%
Dec 31, 2024 1.29%
Sep 30, 2024 13.10%
Jun 30, 2024 13.83%
Mar 31, 2024 12.40%
Dec 31, 2023 8.94%
Sep 30, 2023 8.99%
Jun 30, 2023 10.68%
Mar 31, 2023 14.70%
Dec 31, 2022 15.08%
Sep 30, 2022 10.30%
Jun 30, 2022 14.63%
Mar 31, 2022 11.46%
Dec 31, 2021 15.80%
Sep 30, 2021 16.69%
Jun 30, 2021 17.07%
Mar 31, 2021 23.40%
Dec 31, 2020 22.44%
Sep 30, 2020 20.72%
Jun 30, 2020 21.42%
Mar 31, 2020 33.90%
Dec 31, 2019 41.86%
Sep 30, 2019 21.52%
Jun 30, 2019 20.59%
Mar 31, 2019 19.84%
Dec 31, 2018 21.35%
Sep 30, 2018 22.36%
Jun 30, 2018 17.92%
Mar 31, 2018 16.42%
Dec 31, 2017 14.91%